InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Piekos Brian, Chief Financial Officer. Insider active across 2 companies, notably Gemini Therapeutics, Inc. /DE. Aggregated, 3 reports have been logged. Total volume traded: €120k. The latest transaction was disclosed on 31 May 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations3 total
€10,1149,960 shares@ €1.01557.8% of flow
Common Stock
SEC:0001209191-22-033719:0·
€59,9737,655 shares@ €7.8345100.0% of flow
Common Stock
SEC:0000899243-21-019763·
Ideal exit: 8 Feb 2022 (T+270)
€59,9737,655 shares@ €7.834546.1% of flow
Common Stock
SEC:0000899243-21-019763:0·
Ideal exit: 8 Feb 2022 (T+270)
3 of 3 declarations
About Piekos Brian
Brian Piekos is the Chief Financial Officer at Gemini Therapeutics, Inc. /DE. He is responsible for the financial management of the company, including financial planning and analysis. His expertise is crucial for ensuring the financial health and compliance of the organization.
